ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,438Medicare Part D Prescriptions Filled, Including Refills

Rank: 54 out of 789

$1.37M Total Retail Price of All Prescriptions

Rank: 41 out of 789

1,232 Patients Receiving at Least One Drug in Part D
82% Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Alabama
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 1,232 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 1,232 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 1,154 1,023 216 1 2
LEVOTHYROXINE SODIUM 1,022 915 179 2 3
AMLODIPINE BESYLATE 994 906 181 3 4
SIMVASTATIN 929 810 196 4 5
HYDROCODONE-ACETAMINOPHEN 720 480 176 S3 5 1
ATORVASTATIN CALCIUM 640 561 167 6 8
METFORMIN HCL 484 366 110 7 9
LOSARTAN POTASSIUM 480 434 99 8 12
CLONAZEPAM 444 373 95 B 9 29
NAMENDA 431 405 44 10 44
FUROSEMIDE 416 353 86 11 7
MELOXICAM 393 361 106 12 18
ZOLPIDEM TARTRATE 361 314 68 13 21
CARVEDILOL 351 287 75 14 16
ALPRAZOLAM 338 262 73 B 15 13
CLOPIDOGREL 336 298 67 16 23
LOSARTAN-HYDROCHLOROTHIAZIDE 326 304 65 17 31
DONEPEZIL HCL 325 325 52 18 39
GABAPENTIN 299 225 63 19 11
WARFARIN SODIUM 284 272 63 20 27
POTASSIUM CHLORIDE 282 237 63 21 14
CITALOPRAM HBR 274 237 59 22 25
LORAZEPAM 264 222 68 B 23 37
ESCITALOPRAM OXALATE 261 211 43 24 42
NEXIUM 253 215 39 25 24
HYDROCHLOROTHIAZIDE 252 235 63 26 15
LISINOPRIL 252 226 65 26 6
ALLOPURINOL 251 236 42 28 34
METOPROLOL SUCCINATE 250 230 51 29 20
QUETIAPINE FUMARATE 250 245* 37 A 29 66
MIRTAZAPINE 249 216 45 31 58
PRAVASTATIN SODIUM 248 218 61 32 10
TRAMADOL HCL 224 188 63 33 17
SERTRALINE HCL 224 184 34 33 28
PANTOPRAZOLE SODIUM 213 190 46 35 19
FAMOTIDINE* 212 179 34 36 92
CRESTOR 201 189 52 37 38
METOPROLOL TARTRATE 200 174 41 38 22
GLIMEPIRIDE 183 162 45 39 32
TAMSULOSIN HCL 182 155 40 40 36
AMLODIPINE BESYLATE-BENAZEPRIL 182 158 38 40 54
TEMAZEPAM 178 147 40 B 42 77
FLUTICASONE PROPIONATE 177 125 55 43 41
TORSEMIDE 164 127 38 44 116
CELEBREX 162 136 41 45 82
TRAZODONE HCL 162 127 26 45 33
PAROXETINE HCL 150 138 26 47 69
GEMFIBROZIL 148 131 35 48 114
BYSTOLIC 144 129 27 49 110
ENALAPRIL MALEATE 132 114 28 50 74
SPIRONOLACTONE 129 106 29 51 56
BISOPROLOL-HYDROCHLOROTHIAZIDE 128 112 23 52 100
ATENOLOL 127 122* 25 53 26
ZETIA 120 115* 24 54 79
DIGOX 118 113* 28 55 93
XARELTO 116 105 21 56 167
CLONIDINE HCL 115 80 29 57 35
LYRICA 114 97 18 58 51
GLYBURIDE 99 79 23 R 59 158
LANTUS 96 79 26 60 89
METOCLOPRAMIDE HCL 95 53 15 61 115
BENAZEPRIL HCL 92 87* 20 62 68
LANSOPRAZOLE 91 74 19 63 145
JANUVIA 91 86* 16 63 75
EXELON 90 85* 18 65 142
TRIAMTERENE-HCTZ 88 83* 21 66 43
MONTELUKAST SODIUM 85 74 20 67 40
GLYBURIDE-METFORMIN HCL 85 80* 18 R 67 154
GLIPIZIDE 84 79* 19 69 81
LEVETIRACETAM 84 79* 12 69 122
KLOR-CON 10 81 76* 21 71 104
HUMULIN 70-30 77 <11 <11 72 131
DIOVAN 77 64 17 72 65
METHOCARBAMOL 76 63 29 R 74 99
OXYCODONE-ACETAMINOPHEN 75 70* 39 S2 75 168
CIPROFLOXACIN HCL 73 68* 58 76 55
RAMIPRIL 72 67* 16 77 72
VENLAFAXINE HCL ER 72 61 12 77 96
KLOR-CON M20 71 42 17 79 62
FOSINOPRIL SODIUM 71 <11 <11 79 128
PREDNISONE 71 54 33 79 46
DIGOXIN 70 70 18 82 170
AMITRIPTYLINE HCL 70 65* 12 R 82 59
MECLIZINE HCL 70 49 29 82 83
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 50 17 85 30
DICYCLOMINE HCL 68 63* 15 86 213
LEVOFLOXACIN 66 49 59 87 61
RIVASTIGMINE 65 <11 <11 88 257
ONDANSETRON HCL* 64 33 32 89 161
CEFUROXIME 61 56* 51 90 135
TERAZOSIN HCL 61 61 15 90 165
NOVOLIN R 61 45 13 90 235
VESICARE 60 <11 <11 93 153
OXYCODONE HCL-ACETAMINOPHEN 60 46 19 S2 93 101
AZITHROMYCIN 60 55* 55 93 47
PROPRANOLOL HCL 58 53* 12 96 123
BUSPIRONE HCL 57 <11 <11 97 109
OXYBUTYNIN CHLORIDE ER 57 <11 <11 97 160
DETROL LA 57 <11 <11 97 208
ROPINIROLE HCL 56 51* 17 100 86
TRIAMCINOLONE ACETONIDE 54 49* 35 101 152
DIVALPROEX SODIUM 54 <11 <11 101 127
INSULIN SYRINGE* 52 31 15 103 176
NAPROXEN 52 47* 22 103 98
BACLOFEN 50 <11 <11 105 132
PROMETHAZINE HCL 50 38 23 R 105 80
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.